» Articles » PMID: 35418095

Barriers to Management of Opioid Withdrawal in Hospitals in England: a Document Analysis of Hospital Policies on the Management of Substance Dependence

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2022 Apr 14
PMID 35418095
Authors
Affiliations
Soon will be listed here.
Abstract

Background: People who use illicit opioids are more likely to be admitted to hospital than people of the same age in the general population. Many admissions end in discharge against medical advice, which is associated with readmission and all-cause mortality. Opioid withdrawal contributes to premature discharge. We sought to understand the barriers to timely provision of opioid substitution therapy (OST), which helps to prevent opioid withdrawal, in acute hospitals in England.

Methods: We requested policies on substance dependence management from 135 National Health Service trusts, which manage acute hospitals in England, and conducted a document content analysis. Additionally, we reviewed an Omitted and Delayed Medicines Tool (ODMT), one resource used to inform critical medicine categorisation in England. We worked closely with people with lived experience of OST and/or illicit opioid use, informed by principles of community-based participatory research.

Results: Eighty-six (64%) trusts provided 101 relevant policies. An additional 44 (33%) responded but could not provide relevant policies, and five (4%) did not send a definitive response. Policies illustrate procedural barriers to OST provision, including inconsistent application of national guidelines across trusts. Continuing community OST prescriptions for people admitted in the evening, night-time, or weekend was often precluded by requirements to confirm doses with organisations that were closed during these hours. 42/101 trusts (42%) required or recommended a urine drug test positive for OST medications or opioids prior to OST prescription. The language used in many policies was stigmatising and characterised people who use drugs as untrustworthy. OST was not specifically mentioned in the reviewed ODMT, with 'drugs used in substance dependence' collectively categorised as posing low risk if delayed and moderate risk if omitted.

Conclusions: Many hospitals in England have policies that likely prevent timely and effective OST. This was underpinned by the 'low-risk' categorisation of OST delay in the ODMT. Delays to continuity of OST between community and hospital settings may contribute to inpatient opioid withdrawal and increase the risk of discharge against medical advice. Acute hospitals in England require standardised best practice policies that account for the needs of this patient group.

Citing Articles

Improving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation.

Lewer D, Brown M, Burns A, Eastwood N, Gittins R, Holland A NIHR Open Res. 2024; 4:10.

PMID: 39568556 PMC: 11576563. DOI: 10.3310/nihropenres.13534.2.


Improving hospital care for people who use drugs: deliberative process development of a clinical guideline for opioid withdrawal management.

Wickremsinhe M, Holland A, Scott J, Gittins R, Brown M, Noctor A Harm Reduct J. 2024; 21(1):201.

PMID: 39551775 PMC: 11572091. DOI: 10.1186/s12954-024-01127-2.


Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis.

Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M medRxiv. 2024; .

PMID: 39398993 PMC: 11469356. DOI: 10.1101/2024.09.20.24313898.


"Before medically advised" departure from hospital and subsequent drug overdose: a population-based cohort study.

Khan M, Nicole X, Crabtree A, Moe J, Nasmith T, Daly-Grafstein D CMAJ. 2024; 196(31):E1066-E1075.

PMID: 39313269 PMC: 11426346. DOI: 10.1503/cmaj.240364.


Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: A thematic framework analysis of coroner reports.

Lewer D, Brothers T, Harris M, Rock K, Copeland C PLoS One. 2023; 18(4):e0283549.

PMID: 37075021 PMC: 10115296. DOI: 10.1371/journal.pone.0283549.


References
1.
Doran J, Hope V, Wright T, Scott J, Ciccarone D, Harris M . Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK. Drug Alcohol Rev. 2021; 41(3):677-685. DOI: 10.1111/dar.13389. View

2.
Choi M, Kim H, Qian H, Palepu A . Readmission rates of patients discharged against medical advice: a matched cohort study. PLoS One. 2011; 6(9):e24459. PMC: 3169593. DOI: 10.1371/journal.pone.0024459. View

3.
van Boekel L, Brouwers E, van Weeghel J, Garretsen H . Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013; 131(1-2):23-35. DOI: 10.1016/j.drugalcdep.2013.02.018. View

4.
Doran J, Harris M, Hope V, Wright T, Edmundson C, Sinka K . Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys. Drug Alcohol Depend. 2020; 213:108080. DOI: 10.1016/j.drugalcdep.2020.108080. View

5.
Harris M, Brathwaite R, Scott J, Gilchrist G, Ciccarone D, Hope V . Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. Addiction. 2018; 113(10):1790-1801. DOI: 10.1111/add.14257. View